Medical/Pharmaceuticals
Leaf Space Applies Satellite Solutions to Enhance Connectivity for Home Monitoring of COVID-19 Patients with CARES Monitoring System
GSaaS solutions company is supported by the European Space Agency to test satellite enabled telemedicine technology to remotely care for recovering COVID-19 patients MILAN, July 28, 2021 /PRNewswire/ -- Leaf Space, a leading provider of ground segment as-a-service (GSaaS) solutions, announced to...
2021-07-28 21:00
1178
Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis
HONG KONG, July 28, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce that Fortacin™, a European,Hong Kong andMacau approved treatment for PE receives a detailed market ass...
2021-07-28 20:05
7653
United Imaging Goes "All-in" for Nashville
HOUSTON, July 28, 2021 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, makes its debut at HealthTrust University and its in-person debut at AHRA inNashville over the next two weeks. At both events, the company will focus on several unique ...
2021-07-28 20:00
1193
GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit
PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance...
2021-07-28 19:30
4840
I-Mab Announces IND Acceptance for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
* Efineptakin alfa in combination with pembrolizumab induced 27.8% ORR in metastatic TNBC patients in a phase1b/2 trial in South Korea * Efineptakin alfa in patients with GBM showed a 83.3% survival ratio over one year in a phase 1 trial in the U.S. SHANGHAI and GAITHERSBURG, Md., July 28, 20...
2021-07-28 19:15
4121
BIOTRONIK Applauded by Frost & Sullivan for Its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
LONDON, July 28, 2021 /PRNewswire/ -- Based on its recent analysis of the Global market for implantable cardiac monitoring devices,Frost & Sullivan recognizesBIOTRONIK with the 2021 Global Enabling Technology Leadership Award. The company's subcutaneous miniature, injectable electrocardiogram (EC...
2021-07-28 18:00
1168
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia
SHANGHAI, July 28, 2021 /PRNewswire/ -- Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced the initiation of a Phase 1a clinical trial evaluating ECC0509, an oral inhibitor of semicarbazide-sensitive...
2021-07-28 17:13
1621
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%
HONG KONG, July 28, 2021 /PRNewswire/ -- The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around 50%) for early cancer detection and fails to detect polyps. The Faculty of Medicine at TheChinese University of Hong Kong (CU Medicine)...
2021-07-28 15:09
2470
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China
SUZHOU, China, July 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company has dosed the first batch of subjects in its phase I clinical trial of...
2021-07-28 13:47
4871
Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System
HANGZHOU, China, July 28, 2021 /PRNewswire/ -- On July 27, 2021, Venus Medtech ( Hangzhou) Inc. ("Venus Medtech") (stock code: 2500.HK), a leading provider of comprehensive interventional heart valve therapy solutions inChina, and its controlling subsidiary Renaly Ltd., announced that Professor...
2021-07-28 11:41
4078
India-based MedTel receives investment term sheet from Catalist-listed Metal Component Engineering (MCE, SGX:5DX)
SINGAPORE, July 28, 2021 /PRNewswire/ -- Catalist-listed Metal Component Engineering Limited ("MCE") is pleased to announce that it has, through its subsidiary, Metal Precision Services Pte Ltd, entered into a term sheet to take an equity stake in MedTel Healthcare Private Limited ("MedTel"). MCE...
2021-07-28 11:36
10999
More than Half of Singaporeans Unaware of Link between Viral Hepatitis and Liver Failure: Survey
* New survey demonstrates general apathy among Singaporeans towards liver health, particularly among those aged 25 and below, despite high rates of liver cancer and failure in the country * Hepatitis B causes 60-70% of total number of liver cancer cases in the country[1]; liver cancer known ...
2021-07-28 11:00
1368
Gilead Sciences Announces Launch of Asia Pacific ALL4LIVER Grant 2021
– Biennial Grant Program Supports Community Projects Focused on Improving Education About Liver Health inSingapore and 10 Other Countries and Territories– – Inaugural Cycle of the Grant will Focus on Hepatitis B Awareness Initiatives – SINGAPORE, July 28, 2021 /PRNewswire/ -- Gilead Sciences, I...
2021-07-28 11:00
3472
Ascletis Announces Completion of 149 Patient Enrollment and Positive Interim Results of Phase IIb Chronic Hepatitis B Study in China for its Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab)
* HBsAg reduction was observed in the 1 mg/kg ASC22 once every two weeks plus nucleos(t)ide analogs group with greater HBsAg reduction observed in patients with HBsAg ≤ 500 IU/mL at baseline while no HBsAg reduction was observed for the placebo plus nucleos(t)ide analogs group * Receptor oc...
2021-07-28 08:30
2144
Zepp Health Invests $2.4M to Lead neuro42's Series A Round
CUPERTINO and SAN FRANCISCO, Calif., July 27, 2021 /PRNewswire/ -- Zepp Health Corp. (NYSE: ZEPP), and neuro42, Inc. today announced that Zepp Health is investing$2.4 million to lead the $6.5 million Series A funding round for the development of MRI and robotics technology that allows physicians ...
2021-07-28 04:00
12033
Global Dementia Cases Forecasted To Triple By 2050
—New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors DENVER, July 27, 2021 /PRNewswire/ -- Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year 2050. Mean...
2021-07-27 22:00
2688
Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples
HONG KONG, July 27, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to ann...
2021-07-27 21:39
13495
I-Mab Announces Preliminary Proposal for Potential Dual Listing on the STAR Market of the Shanghai Stock Exchange
SHANGHAI and GAITHERSBURG, Md., July 27, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that onJuly 27, 2021, the Board of Directors of the Comp...
2021-07-27 20:35
11159
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
SHANGHAI, July 27, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 1...
2021-07-27 20:30
2835
VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant
* New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally significant Delta variant of SARS-CoV-2, reducing infectivity of the virus by >99.99% after 30 seconds of exposure * SPL7013, the antiviral agent in V...
2021-07-27 19:53
4451
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 281 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 276 media titles]
2024-04-19 13:25
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3817
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3083
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
3003
